Director Lindell sells 1,347 Chemed (NYSE: CHE) shares at $447.33

Rhea-AI Filing Summary

Chemed Corp director Andrea R. Lindell reported an open-market sale of 1,347 shares of Capital Stock at $447.33 per share. After this transaction, Lindell directly holds 4,578 shares. This filing reflects a discretionary sale by a board member rather than a compensation-related award.

Insider Trade Summary

Net Seller: 1,347 shares

Net Sell 1 txn

Insider LINDELL ANDREA R

Role Director

Sold 1,347 shs ($603K)

Type	Security	Shares	Price	Value
Sale	Capital Stock	1,347	$447.33	$603K

Holdings After Transaction: Capital Stock — 4,578 shares (Direct)

Key Figures

Shares sold: 1,347 shares Sale price: $447.33 per share Shares held after transaction: 4,578 shares

3 metrics

Shares sold 1,347 shares Open-market sale of Capital Stock on 2026-06-09

Sale price $447.33 per share Price for the 1,347 Capital Stock shares sold

Shares held after transaction 4,578 shares Direct holdings following the reported sale

Key Terms

Capital Stock, open-market sale, non-derivative

3 terms

Capital Stock financial

"The transaction involved non-derivative Capital Stock of Chemed Corp."

Capital stock is the total set of shares that represent ownership in a company, including different classes such as common and preferred stock. Think of it as the number and types of slices in a company’s ownership pie: it matters to investors because it determines voting power, entitlement to dividends, and how a company’s value is divided per share, so changes in capital stock can dilute holdings or alter per‑share metrics.

open-market sale financial

"The filing describes the transaction as an open-market sale."

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

non-derivative financial

"The security is classified as a non-derivative position in Capital Stock."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/10/2026 - 01:06 PM Accepted by SEC EDGAR 06/10/2026 - 01:05 PM Learn about SEC filing dates

FAQ

What insider transaction did Chemed (CHE) report for Andrea R. Lindell?

Chemed director Andrea R. Lindell reported selling 1,347 shares of Capital Stock in an open-market transaction. The sale was recorded at a price of $447.33 per share, as disclosed in the Form 4 insider trading report.

At what price did Andrea R. Lindell sell Chemed (CHE) shares?

Andrea R. Lindell sold Chemed Capital Stock at $447.33 per share. This price applies to the 1,347 shares reported in the open-market sale and is the only transaction price disclosed in the Form 4 filing for this date.

How many Chemed (CHE) shares does Andrea R. Lindell hold after the sale?

Following the reported transaction, Andrea R. Lindell directly holds 4,578 shares of Chemed Capital Stock. This post-transaction holding figure is disclosed in the Form 4 as the total number of shares beneficially owned after the open-market sale.

Was the Chemed (CHE) insider transaction a buy or a sell?

The transaction was a sell. The Form 4 identifies the code "S" and describes it as an open-market or private sale, with 1,347 shares of Chemed Capital Stock sold at a reported price of $447.33 per share.

Does the Chemed (CHE) Form 4 involve derivative securities or only common stock?

The reported transaction involves non-derivative Capital Stock only. The Form 4 shows a single entry classified as a non-derivative security, and the derivative summary section is empty, indicating no option or warrant activity in this filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LINDELL ANDREA R

(Last) (First) (Middle)

356 GREEN JACKET COURT

(Street)

AVON LAKE OHIO 44012

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CHEMED CORP [ CHE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Capital Stock	06/09/2026		S		1,347	D	$447.33	4,578	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	Andrea R. Lindell	06/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)